Breaking News Instant updates and real-time market news.

ACT

Ticker changed to AGN

, BAH

Booz Allen

$37.20

0.2 (0.54%)

07:47
11/29/16
11/29
07:47
11/29/16
07:47

Credit Suisse to hold a conference

4th Annual Industrials Conference is being held in Palm Beach, FL on November 29-December 1 with golf and fishing, along with company hosted dinners will beheld on November 29, followed by company presentations on November 30-December 1.

ACT

Ticker changed to AGN

BAH

Booz Allen

$37.20

0.2 (0.54%)

CACI

CACI

$128.15

-0.35 (-0.27%)

FLR

Fluor

$54.06

-0.76 (-1.39%)

GWW

Grainger

$223.59

-2.18 (-0.97%)

RBC

Regal Beloit

$72.20

-0.35 (-0.48%)

RUSHA

Rush Enterprises

$29.09

-0.32 (-1.09%)

SAVE

Spirit Airlines

$53.54

-0.68 (-1.25%)

XPO

XPO Logistics

$44.15

-1.13 (-2.50%)

TEX

Terex

$30.21

-0.7 (-2.26%)

ODFL

Old Dominion

$87.01

-2.08 (-2.33%)

MSM

MSC Industrial

$88.40

-0.86 (-0.96%)

  • 29

    Nov

  • 13

    Dec

  • 23

    Feb

ACT Ticker changed to AGN

03/08/16
WELS
03/08/16
NO CHANGE
WELS
Celgene unlikely to face Abraxane competition before 2021, says Wells Fargo
After Actavis (AGN) sought permission from the FDA to offer a generic version of Celgene's (CELG) cancer treatment, Abraxane, Wells Fargo does not expect Actavis to be able to offer a generic version of the drug before March 2021. Wells estimates that Abraxane's peak annual EPS contribution to Celgene will be 65c. Wells says that Celgene has many pipeline opportunities, and it keeps an Outperform rating on the shares.
BAH Booz Allen
$37.20

0.2 (0.54%)

10/06/16
10/06/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AutoNation (AN) upgraded to Neutral from Sell at Goldman with analyst David Tamberrino saying valuation has bottomed and could be flat to slightly up in the near-term as SAAR bounces around the low-to-mid 17M range. 2. Trina Solar (TSL), Yingli Green Energy (YGE), and JA Solar (JASO) were upgraded to Buy from Sell at Axiom while the firm upgraded SolarCity (SCTY) to Hold from Sell. 3. PNC Financial (PNC) upgraded to Market Perform from Underperform at Raymond James with analyst David Long saying negative earnings revisions over the past two years have likely hit an inflection point. 4. Big 5 Sporting (BGFV) upgraded to Buy from Hold at Deutsche Bank with analyst Mike Baker citing accelerating sales trends and higher earnings power from profitability improvements. 5. Booz Allen (BAH) upgraded to Outperform from Market Perform at Raymond James with analyst Brian Gesuale saying the recent selloff creates an attractive entry point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/18/16
BOFA
11/18/16
UPGRADE
BOFA
Booz Allen upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Ronald Epstein upgraded Booz Allen to Buy and raised its price target to $41 from $33. The analyst said Booz Allen will benefit from a positive inflection in defense spending and increased cyber security by both the commercial sector and US government.
10/06/16
RAJA
10/06/16
UPGRADE
Target $36
RAJA
Outperform
Booz Allen upgraded to Outperform from Market Perform at Raymond James
Raymond James analyst Brian Gesuale upgraded Booz Allen to Outperform and established a $36 price target saying yesterday's selloff creates an attractive entry point. The analyst said they do not expect an adverse impact to Booz Allen's NSA footprint following the latest employee controversy and notes it is only 5% of total revenue. Further, Gesuale said fundamentals are accelerating and earnings revision risk is to the upside.
10/05/16
COWN
10/05/16
NO CHANGE
COWN
Outperform
Impact on Booz Allen from employee arrest unclear, says Cowen
Cowen analyst Cai von Rumohr said it is still unclear what impact the recent arrest of a Booz Allen employee alleged to have stolen classified computer codes while contracted at the NSA may have on the company. Since this incident is the second of its sort involving a Booz Allen employee, after Edward Snowden, it could have an impact on the company's brand image, the analyst said. However, von Rumohr noted that Booz Allen did not face any litigation, lose any contracts, or have any direct impact on its revenues in the wake of the Snowden incident and that its shares bounced back relatively quickly after the fall associated with that event. The firm keeps an Outperform rating on Booz Allen shares.
CACI CACI
$128.15

-0.35 (-0.27%)

11/15/16
DRXL
11/15/16
INITIATION
Target $140
DRXL
Buy
CACI initiated with a Buy at Drexel Hamilton
Drexel Hamilton analyst Brian Ruttenbur initiated CACI with a Buy and a $140 price target.
11/15/16
NBLE
11/15/16
DOWNGRADE
NBLE
Hold
CACI downgraded to Hold from Buy at Noble Financial
Noble Financial analyst Mark Jordan downgraded CACI to Hold citing valuation following recent share strength following the U.S. election.
06/24/16
NBLE
06/24/16
UPGRADE
Target $110
NBLE
Buy
CACI upgraded to Buy from Hold at Noble Financial
Noble upgraded CACI to Buy from Hold and established a $110 price target on shares.
11/29/16
SBSH
11/29/16
DOWNGRADE
Target $86
SBSH
Neutral
SAIC downgraded to Neutral from Buy at Citi
Citi analyst Jonathan Raviv downgraded SAIC (SAIC) to Neutral citing the recent rally in the shares and some overhang from the pending contract transition. The analyst raised his price target for the stock to $86 from $79. Leidos (LDOS) remains Raviv's top pick in the space. He raised his price target for those shares to $60 from $51. He also raised his price target for Buy-rated CACI to $152 from $115.
FLR Fluor
$54.06

-0.76 (-1.39%)

11/18/16
DBAB
11/18/16
NO CHANGE
DBAB
Infrastructure rally has gone 'too far too fast,' says Deutsche Bank
Deutsche Bank analyst Chad Dillard believes the Trump-driven infrastructure rally in the Engineering & Construction space has gone "too far too fast." Post the election, infrastructure E&C shares rose by 20% and price-to-earnings ratios reached prior cyclical peaks, Dillard tells investors in a research note. It looks more likely that funding for a Trump infrastructure plan will be private rather than public, the analyst adds. Dillard notes, however, that he remains positive on the infrastructure theme. He believes the market is being "overly optimistic" towards Jacobs Engineering (JEC) and Fluor (FLR), while shares of AECOM (ACM) still have room to run.
11/04/16
DADA
11/04/16
DOWNGRADE
DADA
Neutral
Fluor downgraded on reduced earnings, growth outlook at DA Davidson
As noted earlier, DA Davidson downgraded Fluor to Neutral from Buy. Analyst John Rogers lowered his estimates for the company after its Q3 EPS miss. Target to $52 from $60.
11/04/16
11/04/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Whole Foods downgraded to Underperform from Neutral at BofA/Merrill with analyst Robert Ohmes saying he sees increased risks to Whole Foods' comp and margin outlook from the difficult operating environment. 2. Michaels (MIK) downgraded to Neutral from Buy at BofA/Merrill with analyst Denise Chai saying competitors are getting more aggressive with increased new store growth and promotions and expects Michaels comps to remain muted and margins to be "flattish." 3. MDC Partners (MDCA) downgraded to Market Perform from Outperform at BMO Capital, to Market Perform from Outperform at Wells Fargo, and to Neutral from Outperform at Wedbush. 4. Fluor (FLR) downgraded to Neutral from Buy at DA Davidson, to Neutral from Outperform at Macquarie, to Hold from Accumulate at Johnson Rice, and to Market Perform from Outperform at William Blair. 5. Cornerstone OnDemand (CSOD) downgraded to Neutral from Outperform at Credit Suisse, to Underweight from Neutral at JPMorgan, to Neutral from Buy at UBS, and to Buy from Strong Buy at Needham. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/08/16
FBCO
11/08/16
DOWNGRADE
Target $49
FBCO
Neutral
Fluor downgraded to Neutral from Outperform at Credit Suisse
Credit Suisse analyst Jamie Cook downgraded Fluor to Neutral and lowered its price target to $49 from $53. Cook remains concerned about slowing project burn-rates, and new awards that are likely pushed out into FY18. He sees few catalysts to get Fluor out of the "penalty box" given earnings visibility remains cloudy and CP Chem problem project is likely to remain an overhang and not likely completed until October 2017.
GWW Grainger
$223.59

-2.18 (-0.97%)

09/08/16
GSCO
09/08/16
NO CHANGE
GSCO
Goldman's Focus List changes
Goldman added Acuity Brands (AYI) & Facebook (FB) to the Focus List and removed Biogen (BIIB), BorgWarner (BWA), Monsanto (MON), and Grainger (GWW). The bank commented Acuity is a beneficiary of the Low Carbon Economy and said Facebook ranks as a low asset-light tech disruptor that is able to leverage its world-leading user base and mobile users to monetize long-term growth.
06/17/16
06/17/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Phillips 66 (PSX) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Evan Calo citing relative share outperformance year-to-date. 2. Grainger (GWW) downgraded to Neutral from Outperform at Credit Suisse with analyst Andrew Buscaglia citing margin pressures and weak pricing in the U.S. 3. Talen Energy (TLN) downgraded to Equal Weight from Overweight at Barclays with analyst Daniel Ford citing valuation, among other reasons. 4. MSC Industrial (MSM) downgraded to Underperform from Neutral at Credit Suisse with analyst Andrew Buscaglia saying stabilizing trends are largely priced in. 5. ONEOK (OKE) downgraded to Hold from Buy at Argus with analyst Stephen Bigger citing the strong run-up in shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/19/16
BMOC
10/19/16
NO CHANGE
BMOC
Grainger gross margin decline is cyclical, says BMO Capital
BMO Capital analyst R. Scott Graham believes that Grainger's stock fell 5% primarily due to the decline in its gross margin. The analyst thinks that bears will blame the gross margin decline on Internet competition and Amazon (AMZN). However, Graham believes that low commodity prices are to blame, and he expects the company's margins to stabilize next year, enabling its bottom line to increase. The analyst keeps an Outperform rating on the shares.
08/25/16
MACQ
08/25/16
INITIATION
Target $274
MACQ
Outperform
Grainger initiated with an Outperform at Macquarie
Macquarie analyst Hamzah Mazari initiated Grainger with an Outperform and $274 price target.
RBC Regal Beloit
$72.20

-0.35 (-0.48%)

09/27/16
GHSC
09/27/16
DOWNGRADE
Target $64
GHSC
Neutral
Regal Beloit downgraded to Neutral from Accumulate at Seaport Global
Seaport Global analyst Walt Liptak downgraded Regal Beloit to Neutral from Accumulate as he believes its 2016 outlook remains uncertain due to its exposure, both directly and indirectly, to the Oil and Gas sector. The analyst cut his price target on Regal Beloit shares to $64 from $68.
08/02/16
BMOC
08/02/16
DOWNGRADE
BMOC
Market Perform
Regal Beloit downgraded on factory weakness, steel prices at BMO Capital
As noted earlier, BMO Capital downgraded Regal Beloit to Market Perform from Outperform. As reasons for the downgrade, analyst R. Scott Graham cited weakening factory spending and higher steel prices. Target to $66 from $76.
08/02/16
BMOC
08/02/16
DOWNGRADE
BMOC
Market Perform
Regal Beloit downgraded to Market Perform from Outperform at BMO Capital
05/11/16
MSCO
05/11/16
DOWNGRADE
MSCO
Equal Weight
Regal Beloit downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst led by Nigel Coe downgraded Regal Beloit to Equal Weight and reduced its price target to $62 from $65 following the "sizeable" Q1 miss and guidance cut. The analyst believes there will be persistent concerns around the 2016 plan and achievability given its back-end loaded.
RUSHA Rush Enterprises
$29.09

-0.32 (-1.09%)

07/15/16
SPHN
07/15/16
DOWNGRADE
SPHN
Equal Weight
Rush Enterprises downgraded to Equal Weight from Overweight at Stephens
Stephens downgraded Rush Enterprises to Equal Weight citing balanced risk/reward.
02/16/16
SPHN
02/16/16
UPGRADE
Target $22
SPHN
Overweight
Rush Enterprises upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Brad Delco upgraded Rush Enterprises to Overweight from Equal Weight, as he believes shares have limited downside following their post-earnings selloff. Rush Enterprises shares are currently trading at 1.1x tangible book value and the stock has only traded below tangible book value on 18 trading days in the last 12 years, Delco pointed out in his note to investors. The analyst, who remains confident that Rush will keep posting positive EPS quarters going forward, lowered his price target on the stock to $22 from $28.
05/10/16
BOFA
05/10/16
UPGRADE
BOFA
Buy
Rush Enterprises upgraded to Buy from Neutral at BofA/Merrill
10/11/16
STFL
10/11/16
INITIATION
STFL
Hold
Rush Enterprises initiated with a Hold at Stifel
Stifel analyst Michael Baudendistel started Rush Enterprises with a $22 price target and a Hold rating.
SAVE Spirit Airlines
$53.54

-0.68 (-1.25%)

09/29/16
IMPC
09/29/16
INITIATION
Target $51
IMPC
Outperform
Spirit Airlines initiated with an Outperform at Imperial Capital
Imperial Capital analyst Michael Derchin started Spirit Airlines with an Outperform rating and $51 price target.
08/04/16
08/04/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Texas Instruments (TXN) upgraded to Neutral from Underperform at Exane BNP Paribas. 2. Spirit Airlines (SAVE) upgraded to Strong Buy from Outperform at Raymond James with analyst Savanthi Syth saying the recent weakness in the shares brings a "very attractive entry point." 3. Archer Daniels (ADM) upgraded to Buy from Hold at Argus with analyst David Coleman citing valuation and management's optimistic outlook for the second half of 2016. 4. Celgene (CELG) upgraded to Buy from Neutral at BTIG. Analyst Dane Leone believes the company's 2020 financial targets are achievable and represent upside to current consensus estimates. 5. Apollo Global (APO) upgraded to Outperform from Perform at Oppenheimer and to Outperform from Market Perform at Keefe Bruyette. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/04/16
RAJA
08/04/16
UPGRADE
Target $59
RAJA
Strong Buy
Spirit Airlines upgraded to Strong Buy from Outperform at Raymond James
Raymond James analyst Savanthi Syth upgraded Spirit Airlines to Strong Buy saying the recent weakness in the shares brings a "very attractive entry point." The analyst admits there is a lack of near-term catalysts and that Zika is likely to remain a headline risk, however. Syth has a $59 price target for the shares.
11/18/16
SBSH
11/18/16
DOWNGRADE
Target $61
SBSH
Neutral
Spirit Airlines downgraded to Neutral from Buy at Citi
Citi downgraded Spirit Airlines to Neutral after transferring coverage from Stephen Trent to Kevin Crissey. The nearly 40% stock rally over the past two months has "materially reduced" the upside potential in the name, Crissey tells investors in a research note. He raised his price target for the shares to $61 from $52.
XPO XPO Logistics
$44.15

-1.13 (-2.50%)

10/28/16
SBSH
10/28/16
NO CHANGE
Target $38
SBSH
Buy
XPO Logistics TL sale a 'solid positive,' says Citi
Citi analyst Christian Wetherbee views XPO Logistics' sale of its TL business as a "solid positive" for its leverage, free cash flow and valuation. XPO will use the proceeds to delever and the asset intensity of the TL business took away from the free cash flow story and likely valuation, Wetherbee tells investors in a research note. He expects a positive share price reaction today and reiterates a Buy rating on XPO with a $38 price target.
11/02/16
DBAB
11/02/16
INITIATION
Target $60
DBAB
Buy
XPO Logistics initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Amit Mehrotra started XPO Logistics with a Buy rating and $60 price target. The analyst calls XPO his top Transportation pick. He sees 80% upside as management's "massive transformation enters harvesting stage."
08/09/16
OPCO
08/09/16
NO CHANGE
Target $42
OPCO
Outperform
XPO Logistics price target raised to $42 from $33 at Oppenheimer
Oppenheimer analyst Scott Schneeberger raised his price target for XPO Logistics to $42 from $33 following a "strong" Q2. The analyst envisions potential multiple enhancement over coming years as Con-way synergies/operational efficiencies are achieved, margin expands/free cash flow builds and financial leverage declines. Schneeberger reiterates an Outperform rating on the shares.
11/23/16
SBSH
11/23/16
NO CHANGE
Target $54
SBSH
Buy
XPO Logistics price target raised to $54 from $38 at Citi
Citi analyst Christian Wetherbee raised his price target for XPO Logistics to $54 after hosting meeting with the company's management. The investment case is as strong as it's been, Wetherbee tells investors in a research note. The analyst sees potential for multiple expansion now that XPO "has pivoted into the execution phase of its life cycle." He reiterates a Buy rating on the shares.
TEX Terex
$30.21

-0.7 (-2.26%)

10/14/16
BOFA
10/14/16
UPGRADE
Target $29
BOFA
Buy
Terex upgraded to Buy from Underperform at BofA/Merrill
BofA/Merrill analyst Ross Gilardi upgraded Terex two notches to Buy from Underperform and raised its price target to $29 from $21 saying the $1.3B sale of its Material Handling and Ports Solutions, or MHPS, to Konecranes provides "unprecedented financial flexibility." Gilardi said Terex now has the capability to cope with weak operating conditions and expects further portfolio rationalization announcements over the next 3-6 months, and potentially even the divestiture of its remaining Construction assets.
11/18/16
LYON
11/18/16
DOWNGRADE
LYON
Underperform
Terex downgraded to Underperform from Buy at CLSA
CLSA downgraded Terex to Underperform from Buy saying current valuation is stretched.
10/24/16
LEHM
10/24/16
DOWNGRADE
Target $20
LEHM
Underweight
Terex downgraded to Underweight from Equal Weight at Barclays
Barclays analyst Robert Wertheimer downgraded Terex to Underweight after cutting the U.S. Machinery sector to Negative from Neutral. The analyst believes the "weak" replacement cycle is underappreciated by investors. He keeps a $20 price target for the shares.
11/01/16
WELS
11/01/16
NO CHANGE
WELS
Terex shares should be bought on any weakness, says Wells Fargo
After Terex reported weaker than expected Q3 results, Wells Fargo says that conditions in the company's market "remain difficult." But the firm is upbeat on the company's strategy ,and it believes that the company's initiatives will help the company in the future. It recommends buying the shares on any weakness and keeps an Outperform rating on the shares.
ODFL Old Dominion
$87.01

-2.08 (-2.33%)

10/28/16
10/28/16
DOWNGRADE
Target $73

Underperform
Old Dominion downgraded to Underperform on rich valuation at BofA/Merrill
As previously reported, BofA/Merrill downgraded Old Dominion to Underperform and raised its price target to $73 from $72. Analyst Ariel Rosa said Old Dominion's premium valuation does not reflect the "tepid" demand environment and limited tonnage growth.
10/28/16
BOFA
10/28/16
DOWNGRADE
BOFA
Underperform
Old Dominion downgraded to Underperform from Neutral at BofA/Merrill
04/28/16
STFL
04/28/16
DOWNGRADE
STFL
Hold
Old Dominion downgraded to Hold from Buy at Stifel
11/02/16
DBAB
11/02/16
INITIATION
Target $90
DBAB
Buy
Old Dominion initiated with a Buy at Deutsche Bank
Deutsche Bank analyst Amit Mehrotra started Old Dominion with a Buy rating and $90 price target.
MSM MSC Industrial
$88.40

-0.86 (-0.96%)

08/19/16
FBCO
08/19/16
INITIATION
Target $65
FBCO
Underperform
MSC Industrial initiated with an Underperform at Credit Suisse
Credit Suisse analyst Andrew Buscaglia reinstated coverage on MSC Industrial with an Underperform and $65 price target saying the difficult environment may mean trough margins are further out than expected and valuation is stretched.
11/21/16
SPHN
11/21/16
UPGRADE
SPHN
Overweight
MSC Industrial upgraded to Overweight from Equal Weight at Stephens
08/25/16
MACQ
08/25/16
INITIATION
Target $80
MACQ
Neutral
MSC Industrial initiated with a Neutral at Macquarie
Macquarie analyst Hamzah Mazari initiated MSC Industrial with a Neutral and $80 price target.

TODAY'S FREE FLY STORIES

ALNY

Alnylam

$42.25

1.445 (3.54%)

16:16
12/09/16
12/09
16:16
12/09/16
16:16
Hot Stocks
Breaking Hot Stocks news story on Alnylam »

Dodge & Cox reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

$NYE

NYSE Market Internals

16:16
12/09/16
12/09
16:16
12/09/16
16:16
Technical Analysis
NYSE market internals summary »

Breadth is mixed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVO

Cenveo

$6.84

-0.16 (-2.29%)

16:16
12/09/16
12/09
16:16
12/09/16
16:16
Hot Stocks
Breaking Hot Stocks news story on Cenveo »

Brigade Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

16:16
12/09/16
12/09
16:16
12/09/16
16:16
Technical Analysis
NASDAQ market internals summary »

Volume is very heavy for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$1.33

-0.04 (-2.92%)

16:15
12/09/16
12/09
16:15
12/09/16
16:15
Hot Stocks
Cellectar, INC Research enter into Work Order »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSW

International Seaways

$14.40

0.86 (6.35%)

16:12
12/09/16
12/09
16:12
12/09/16
16:12
Hot Stocks
Breaking Hot Stocks news story on International Seaways »

Cyrus Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BFS

Saul Centers

$66.45

-0.96 (-1.42%)

16:09
12/09/16
12/09
16:09
12/09/16
16:09
Hot Stocks
Saul Centers raises quarterly dividend 8.5% to 51c from 47c per share »

The dividend is to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASNA

Ascena Retail

$8.04

-0.07 (-0.86%)

16:08
12/09/16
12/09
16:08
12/09/16
16:08
Hot Stocks
Ascena Retail names David Jaffe chairman of the board »

Ascena Retail announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MORN

Morningstar

16:08
12/09/16
12/09
16:08
12/09/16
16:08
Hot Stocks
Morningstar raises quarterly dividend to 23c from 22c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAND

Sandstorm Gold

$3.83

-0.19 (-4.73%)

16:07
12/09/16
12/09
16:07
12/09/16
16:07
Syndicate
Breaking Syndicate news story on Sandstorm Gold »

Sandstorm Gold files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACIU

AC Immune

$14.93

2.88 (23.90%)

, RHHBY

Roche

$27.86

0.78 (2.88%)

16:05
12/09/16
12/09
16:05
12/09/16
16:05
Hot Stocks
AC Immune partner Genentech presents 'important' data on Alzheimer's therapy »

AC Immune (ACIU)…

ACIU

AC Immune

$14.93

2.88 (23.90%)

RHHBY

Roche

$27.86

0.78 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDVX

Medovex

$1.50

0.03 (2.04%)

16:03
12/09/16
12/09
16:03
12/09/16
16:03
Hot Stocks
Breaking Hot Stocks news story on Medovex »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDC

Belden

$78.79

-1.69 (-2.10%)

16:01
12/09/16
12/09
16:01
12/09/16
16:01
Hot Stocks
Belden extends shareholder rights agreement »

Belden announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GENE

Genetic Technologies

$1.19

-0.01 (-0.83%)

15:59
12/09/16
12/09
15:59
12/09/16
15:59
Hot Stocks
Breaking Hot Stocks news story on Genetic Technologies »

CVI Investments reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLO

Flowers Foods

$19.26

2.2325 (13.11%)

15:53
12/09/16
12/09
15:53
12/09/16
15:53
Recommendations
Flowers Foods analyst commentary  »

Flowers Foods settlement…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$54.22

-0.21 (-0.39%)

15:50
12/09/16
12/09
15:50
12/09/16
15:50
Options
Halliburton Dec 48.5 puts for a nickel per contract »

Halliburton Dec 48.5 puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

BIIB

Biogen

$289.54

4.24 (1.49%)

15:43
12/09/16
12/09
15:43
12/09/16
15:43
Recommendations
Biogen analyst commentary  »

Piper says Biogen still…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VLO

Valero

$67.84

-0.535 (-0.78%)

15:40
12/09/16
12/09
15:40
12/09/16
15:40
Options
Higher option volume in Valero driven by downside put purchases »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKLN

Skyline Medical

$2.94

-0.01 (-0.34%)

15:36
12/09/16
12/09
15:36
12/09/16
15:36
Syndicate
Skyline Medical files to sell 1.925M units »

Each unit consisting of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMNY

Helios and Matheson

$4.26

-0.08 (-1.84%)

15:35
12/09/16
12/09
15:35
12/09/16
15:35
Hot Stocks
Farnsworth acquires 1.74M Helios and Matheson shares as part of merger pact »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FLO

Flowers Foods

$19.10

2.07 (12.16%)

15:32
12/09/16
12/09
15:32
12/09/16
15:32
Upgrade
Flowers Foods rating change  »

Flowers Foods upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBA

Walgreens Boots Alliance

$84.28

-0.71 (-0.84%)

, RAD

Rite Aid

$8.20

0.045 (0.55%)

15:25
12/09/16
12/09
15:25
12/09/16
15:25
Periodicals
Walgreens near finalizing Rite Aid divestiture package, CTFN reports »

Walgreens (WBA) is…

WBA

Walgreens Boots Alliance

$84.28

-0.71 (-0.84%)

RAD

Rite Aid

$8.20

0.045 (0.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

BAS

Basic Energy

$0.44

-0.0039 (-0.89%)

15:19
12/09/16
12/09
15:19
12/09/16
15:19
Hot Stocks
Breaking Hot Stocks news story on Basic Energy »

Basic Energy trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:16
12/09/16
12/09
15:16
12/09/16
15:16
Technical Analysis
NYSE market internals summary »

Breadth is mixed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

15:16
12/09/16
12/09
15:16
12/09/16
15:16
Technical Analysis
NASDAQ market internals summary »

Volume is heavy for this…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.